Alfred Sandrock, Group SVP, Chief Medical Officer at BIOGEN INC. (BIIB), sold 430 shares at $430.12 ($185K) on 2015-03-27, disclosed to the SEC on 2015-03-30.
Scheduled sale ($185k) by Group SVP, Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-20 | $40K | — | Filing → |
| VYGR | SELL | 2026-02-11 | $46K | — | Filing → |
| VYGR | SELL | 2025-04-04 | $37K | — | Filing → |